The procedure of IHC and ICC staining was shown in the previous studies [52 (link)]. LGR6 staining was evaluated blindly and independently by two pathologists. The score for staining intensity (0 = no staining, 1 = light brown, 2 = brown, and 3 = dark brown) and staining frequency (0 = 0–10%, 1 = 11–25%, 2 = 26–50%, 3 = 51–75%, and 4 = 76–100%) were multiplied to obtain the immunoreactivity score (IRS). The IRS 0–3 was deemed negative, 4–6 weak positive, and >6 strong positive. Two different pathologists evaluated all the specimens in a blinded manner. The antibodies used were as follows: anti-LGR6 (#MAB8458, R&D Systems, USA), anti-β-catenin (#sc-7963, Santa Cruz, USA), anti-TCF7L2 (#sc-166699, Santa Cruz, USA), anti-c-Myc (#10828-1-AP, Proteintech, China), OCT4 (#sc-5279, Santa Cruz, USA), anti-SOX2 (#3579, Cell Signaling Technology, USA), anti-KLF4 (#sc-20691, Santa Cruz, USA), anti-ALDH1A1 (#sc-374149, Santa Cruz, USA), anti-LGR5 (#PAB2591, Abnova, Taiwan), anti-LGR4 (#sc-390630, Santa Cruz, USA).
Free full text: Click here